Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

Psychopharmacology

Volumn 148, Issue 1, 2000, Pages 83-89

  Spina, Edoardo ^d   Avenoso, Angela ^d   Facciolà, Gabriella ^d   Scordo, Maria G ^d   Ancione, Maria ^a   Madia, Aldo G ^a   Ventimiglia, Andrea ^b   Perucca, Emilio ^c  

^a Azienda USL Messina 5   (Italy)

^b Villa dei Gerani Clinic   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Clozapine; Norclozapine; Plasma concentration; Schizophrenia; Therapeutic drug monitoring

Indexed keywords

CLOZAPINE; NORCLOZAPINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONSTIPATION; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSALIVATION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SEDATION; STEADY STATE; TACHYCARDIA; VERTIGO; WEIGHT GAIN;

EID: 0002310994     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050028     Document Type: Article

References (25)

1. Ackenheil M (1989) Clozapine: pharmacokinetic investigations and biochemical effects in man. Psychopharmacology 99:32-37
2. Ackenheil VM, Brau H, Burkhart A, Franke A, Pacha W (1976) Antipsychotic efficacy in relation to plasma levels of clozapine. Arzneimittelforschung 26:1156-1158 (German; English abstract)
3. Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 329:162-167
4. Avenoso A, Facciolà G, Campo GM, Fazio A, Spina E (1998) Determination of clozapine, desmethylclozapine and clozapine n-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B 714:299-308
5. Baldessarini RJ, Frankenburg FR (1991) Clozapine. A novel anti-psychotic agent. N Engl J Med 324:746-754
6. Brau VH, Burkhart A, Pacha W, Ackenheil VM (1978) Relationships between effects and plasma levels of clozapine. Arzneimittelforschung 28:1300 (German; English abstract)
7. Devinsky O, Honigfeld G, Patin J (1991) Clozapine-related seizures. Neurology 41:369-371
8. Edge SC, Markovitz JS, DeVane CL (1997) Clozapine drug-drug interactions: a review of the literature. Hum Psychopharmacol 12:5-20
9. Freeman DJ, Oyewumi LK (1997) Will routine therapeutic drug monitoring have a place in clozapine therapy? Clin Pharmacokinet 32:93-100
10. Haring C, Fleishacker WW, Schett P, Humpel C, Barnas C, Saria A (1990) Influence of patient-related variables on clozapine plasma concentrations. Am J Psychiatry 147:1471-1475
11. Hasegawa M, Gutierrez-Esteinou R, Way L, Meltzer HY (1993) Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. J Clin Psychopharmacol 13:383-390
12. Hu RJ, Malhotra AK, Pickar D (1999) Predicting response to clozapine: status of current research. CNS Drugs 11:317-326
13. Jann MW, Grimsley SR, Gray EC, Chang WH (1993) Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 24:161-176
14. Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenia: a double blind comparison versus chlorpromazine. Arch Gen Psychiatry 45:789-796
15. Kronig MH, Munne RA, Szymanski S, Safferman AZ, Pollack S, Cooper T, Kane JM, Lieberman JA (1995) Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. Am J Psychiatry 152:179-182
16. Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM (1994) Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 151: 1744-1752
17. Meltzer HY, Burnett S, Bastani B, Ramirez LF (1990) Effect of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Commun Psychiatry 41: 892-897
18. Miller DD, Fleming P, Holman TL (1994) Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. J Clin Psychiatry 55:117-121
19. Olesen OV (1998) Therapeutic drug monitoring of clozapine treatment: therapeutic threshold value for serum clozapine concentrations. Clin Pharmacokinet 34:497-502
20. Olesen OV, Thomsen K, Jensen PN, Wulff CH, Rasmussen NA, Refshammer C, Sorensen J, Bysted M, Christensen J, Rosenberg R (1995) Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study. Psychopharmacology 117:371-378
21. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
22. Perry PJ, Miller DD, Arndt SV, Cadoret RJ (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 148:231-235
23. Potkin SG, Bera R, Gulasekaram B, Costa J, Hayes S, Jin Y, Richmond G, Carreon D, Sitanggan K, Gerber B, Telford J, Plon L, Plon H, Park L, Chang JJ, Oldroyd J, Cooper T (1994) Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry 55:133-136
24. Thorup M, Fog R (1977) Clozapine treatment of schizophrenic patients: plasma concentration and coagulation factors. Acta Psychiatr Scand 66:123-126
25. Van der Zwaag C, McGee M, McEvoy JP, Freudenreich O, Wilson WH, Cooper TB (1996) Response of patients with treatment-resistant schizophrenia to clozapine within three serum level ranges. Am J Psychiatry 153:1579-1584